[go: up one dir, main page]

ITRM20010336A1 - Anticorpo umano ricombinante diretto contro la proteina non strutturale ns3 del virus dell'epatite c (hcv), acido nucleico codificante e usi - Google Patents

Anticorpo umano ricombinante diretto contro la proteina non strutturale ns3 del virus dell'epatite c (hcv), acido nucleico codificante e usi

Info

Publication number
ITRM20010336A1
ITRM20010336A1 IT2001RM000336A ITRM20010336A ITRM20010336A1 IT RM20010336 A1 ITRM20010336 A1 IT RM20010336A1 IT 2001RM000336 A IT2001RM000336 A IT 2001RM000336A IT RM20010336 A ITRM20010336 A IT RM20010336A IT RM20010336 A1 ITRM20010336 A1 IT RM20010336A1
Authority
IT
Italy
Prior art keywords
hcv
human antibody
nucleic acid
recombinant human
antibody against
Prior art date
Application number
IT2001RM000336A
Other languages
English (en)
Inventor
Roberto Burioni
Massimo Clementi
Original Assignee
Biostrands S R L
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biostrands S R L filed Critical Biostrands S R L
Priority to IT2001RM000336A priority Critical patent/ITRM20010336A1/it
Publication of ITRM20010336A0 publication Critical patent/ITRM20010336A0/it
Priority to PCT/IT2002/000384 priority patent/WO2002100900A2/en
Priority to AT02745784T priority patent/ATE430167T1/de
Priority to DK02745784T priority patent/DK1417233T3/da
Priority to DE60232155T priority patent/DE60232155D1/de
Priority to AU2002317474A priority patent/AU2002317474A1/en
Priority to US10/480,843 priority patent/US7314919B2/en
Priority to EP02745784A priority patent/EP1417233B1/en
Publication of ITRM20010336A1 publication Critical patent/ITRM20010336A1/it

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
    • C07K16/1081—Togaviridae, e.g. flavivirus, rubella virus, hog cholera virus
    • C07K16/109—Hepatitis C virus; Hepatitis G virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/21—Immunoglobulins specific features characterized by taxonomic origin from primates, e.g. man
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
    • C07K2317/55—Fab or Fab'
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2799/00—Uses of viruses
    • C12N2799/02—Uses of viruses as vector
    • C12N2799/021—Uses of viruses as vector for the expression of a heterologous nucleic acid
    • C12N2799/028—Uses of viruses as vector for the expression of a heterologous nucleic acid where the vector is derived from a herpesvirus

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
IT2001RM000336A 2001-06-13 2001-06-13 Anticorpo umano ricombinante diretto contro la proteina non strutturale ns3 del virus dell'epatite c (hcv), acido nucleico codificante e usi ITRM20010336A1 (it)

Priority Applications (8)

Application Number Priority Date Filing Date Title
IT2001RM000336A ITRM20010336A1 (it) 2001-06-13 2001-06-13 Anticorpo umano ricombinante diretto contro la proteina non strutturale ns3 del virus dell'epatite c (hcv), acido nucleico codificante e usi
PCT/IT2002/000384 WO2002100900A2 (en) 2001-06-13 2002-06-11 Human recombinant antibody against the hepatitis c (hcv) non structural ns3 protein, nucleic acid and uses thereof
AT02745784T ATE430167T1 (de) 2001-06-13 2002-06-11 Humaner rekombinanter antikörper gegen das hepatitis c (hcv) nichtstrukturelles ns3 protein, nukleinsäure und deren verwendungen
DK02745784T DK1417233T3 (da) 2001-06-13 2002-06-11 Humant rekombinant antistof mod det hepatitis C (HCV) ikke-strukturelle NS3-protein, nukleinsyre og anvendelser deraf
DE60232155T DE60232155D1 (de) 2001-06-13 2002-06-11 Humaner rekombinanter antikörper gegen das hepatitis c (hcv) nichtstrukturelles ns3 protein, nukleinsäure und deren verwendungen
AU2002317474A AU2002317474A1 (en) 2001-06-13 2002-06-11 Human recombinant antibody against the hepatitis c (hcv) non structural ns3 protein, nucleic acid and uses thereof
US10/480,843 US7314919B2 (en) 2001-06-13 2002-06-11 Human recombinant antibody against the hepatitis C (HCV) non structural NS3 protein nucleic acid and uses thereof
EP02745784A EP1417233B1 (en) 2001-06-13 2002-06-11 Human recombinant antibody against the hepatitis c (hcv) non structural ns3 protein, nucleic acid and uses thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT2001RM000336A ITRM20010336A1 (it) 2001-06-13 2001-06-13 Anticorpo umano ricombinante diretto contro la proteina non strutturale ns3 del virus dell'epatite c (hcv), acido nucleico codificante e usi

Publications (2)

Publication Number Publication Date
ITRM20010336A0 ITRM20010336A0 (it) 2001-06-13
ITRM20010336A1 true ITRM20010336A1 (it) 2002-12-13

Family

ID=11455593

Family Applications (1)

Application Number Title Priority Date Filing Date
IT2001RM000336A ITRM20010336A1 (it) 2001-06-13 2001-06-13 Anticorpo umano ricombinante diretto contro la proteina non strutturale ns3 del virus dell'epatite c (hcv), acido nucleico codificante e usi

Country Status (8)

Country Link
US (1) US7314919B2 (it)
EP (1) EP1417233B1 (it)
AT (1) ATE430167T1 (it)
AU (1) AU2002317474A1 (it)
DE (1) DE60232155D1 (it)
DK (1) DK1417233T3 (it)
IT (1) ITRM20010336A1 (it)
WO (1) WO2002100900A2 (it)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2004212641B2 (en) * 2003-02-19 2009-08-06 Merck Millipore Ltd. Composite materials comprising supported porous gels
DE602006012836D1 (de) * 2005-06-02 2010-04-22 Akira Matsumori Verfahren zur sichtung von anti-hepatits c virus kandidaten
US7705138B2 (en) * 2005-11-11 2010-04-27 Vertex Pharmaceuticals Incorporated Hepatitis C virus variants
KR20140098867A (ko) 2005-11-11 2014-08-08 버텍스 파마슈티칼스 인코포레이티드 Ｃ형 간염 바이러스 변이체
US7858752B2 (en) * 2006-12-05 2010-12-28 Abbott Laboratories Recombinant antibodies against hepatitis C virus and methods of obtaining and using same
ES2456961T3 (es) 2007-02-21 2014-04-24 University Of Massachusetts Anticuerpos humanos contra el virus de la hepatitis C (VHC), usos de los mismos
ES2385451T3 (es) 2009-07-10 2012-07-25 Freie Universität Berlin Rock2 y Rock3, dos nuevas variantes de ganancia de función de los receptores de citoquinina AHK2 y AHK3

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6194140B1 (en) * 1990-04-04 2001-02-27 Chiron Corporation HCV NS3 protein fragments having helicase activity and improved solubility
AU7877900A (en) * 1999-10-13 2001-04-23 Chiron Corporation Method of obtaining cellular immune responses from proteins

Also Published As

Publication number Publication date
EP1417233B1 (en) 2009-04-29
ATE430167T1 (de) 2009-05-15
ITRM20010336A0 (it) 2001-06-13
EP1417233A2 (en) 2004-05-12
DE60232155D1 (de) 2009-06-10
WO2002100900A2 (en) 2002-12-19
WO2002100900A3 (en) 2004-03-04
US7314919B2 (en) 2008-01-01
AU2002317474A1 (en) 2002-12-23
DK1417233T3 (da) 2009-06-29
US20040214994A1 (en) 2004-10-28

Similar Documents

Publication Publication Date Title
IT1278077B1 (it) Metodologia per riprodurre in vitro le attivita' di rna polimerasi rna-dipendente e di nucleotidiltransferasi terminale codificate dal
DE69922958D1 (de) Hcv hüllproteine partikel : verwendung für therapeutische impfung
BRPI0510527A (pt) método de estabilização de proteìnas
SE9004010D0 (sv) Viralt medel
EP1043399A3 (de) Hepatitis C Virus Zellkultursystem
ATE508184T1 (de) Hcv-polyprotein ns3/ns4 und hcv-polypeptid ns5b enthaltende komposition, entsprechende nukleinsequenzen umfassende expressionsvektoren und therapeutische anwendung davon
ATE405647T1 (de) Rekombinantes gelatin in impstoffen
CY1110437T1 (el) Χρηση παραγωγων καστανοσπερμινης για την θεραπεια της ηπατιτιδας c
EA200401405A1 (ru) Модифицированный осповакцинный вирус анкара для вакцинации новорожденных
EE200200709A (et) Liitvalku sisaldava kompositsiooni ning seda liitvalku ja liitpolüpeptiidi kodeeriva nukleiinhappe kasutamine
DE60330923D1 (de) Menschliche Koagulationsfaktor VII Polypeptide
MXPA05005202A (es) Vacuna.
WO2004085633A8 (en) A novel human virus causing severe acute respiratory syndrome (sars) and uses thereof
WO2004076619A3 (en) New dengue and west nile viruses proteins and genes coding the foregoing, and their use in vaccinal, therapeutic and diagnostic applications
ITRM20010336A1 (it) Anticorpo umano ricombinante diretto contro la proteina non strutturale ns3 del virus dell'epatite c (hcv), acido nucleico codificante e usi
WO2003004627A3 (fr) Lignees d'hepatomes humains leurs optentions et leurs applications
WO2001021807A8 (en) Hepatitis c virus envelope two protein (e2) which lacks all or part of the hypervariable region one (hvr1), corresponding nucleic acids, chimeric viruses and uses thereof
ATE534666T1 (de) Antikörper gegen den hepatitis c-virus e1e2 komplex und pharmazeutische zusammensetzungen
EP1797112A4 (en) INHIBITORS OF HEPATITIS C VIRUS
TW200509964A (en) VP1 of foot-and-mouth disease virus
DE50212580D1 (de) Rekombinantes mva mit der fähigkeit zur expression von hcv struktur-antigenen
WO2004014936A3 (fr) Melange de peptides issus des proteines c et ns3 du virus de l'hepatite c et leurs applications.
DE69718911D1 (de) Interleukin - 8 als antivirale- und antitumorwirkstoffe
ATE542140T1 (de) Nichtstrukturelle hcv-proteinmutanten und verwendungsmöglichkeiten dafür
SE0002498D0 (sv) Papillomavirus vaccine